Inflammatory dermatitis is characterized by epidermal barrier disruption, cutaneous inflammation, and dysregulated cytokine responses. Aster yomena (AY), an edible medicinal plant traditionally used in Korea, has been reported to possess anti-inflammatory properties. This study evaluated the effects of orally administered AY extract in a 2,4-dinitrochlorobenzene (DNCB)-induced dermatitis model using SKH-1 hairless mice. Mice were assigned to six groups (n = 5 per group) and treated during a 5-week experimental period. Mice were assigned to normal control, DNCB-treated control, dexamethasone-treated positive control, and AY extract-treated groups. Gross skin lesions, relative spleen weight, serum interleukin-4 (IL-4) levels, and histopathological changes were assessed. DNCB-treated mice developed marked crusting, dryness, swelling, increased relative spleen weight, elevated serum IL-4 levels, and epidermal hyperplasia with dermal inflammation. Oral administration of AY extract improved gross lesions, reduced relative spleen weight and serum IL-4 levels, and attenuated epidermal thickening, edema, and inflammatory cell infiltration. These findings indicate that AY extract showed preliminary anti-inflammatory and antidermatitic effects in a DNCB-induced SKH-1 hairless mouse model and warrant further mechanistic and translational studies.